Image from Newsday. https://www.newsday.com/opinion/editorial/cure-vaccine-immunity-coronavirus-covid-19-rush-trump-science-1.48679327 With everyone is rushing to return pre-pandemic society, it is becoming clear that a vaccine is the only way to truly get there. Anxiously, the world waits on a vaccine for COVID-19 to get us back to work, back to school, back to play, and back to basic human connection. In
Details

Mergers and acquisitions are a hot topic in the biopharmaceutical industry. With 2019 setting records in terms of deal value and volume for biopharmaceutical M&A, many question the purpose of these processes. In addition to increasing shareholder value, management pursues mergers and acquisitions for a variety of reasons including innovation, synergy, and portfolio realignment. In
Details

In a relatively quick ruling, one that Amarin expected to occur in Q4 at the earliest, the U.S Court of Appeals for the Federal Circuit in Washington invalidated Amarin’s six patents. Essentially, this upheld the decision by the U.S District Court for the District of Nevada that Amarin’s patents for Vascepa, were a variation of
Details

Time is ticking! Need to optimize the value of a new therapy before generics are available. How can we extend the patent? These are all top of mind when developing, commercializing and managing the life cycle of a therapy. Unless engaged heavily in government affairs, it is easy to miss that this is all guided
Details

In a recent interview with Fox News host Chris Wallace, US President Donald Trump discussed his success taking the Montreal Cognitive Assessment (MoCA). The President appeared quite proud to have achieved a perfect score. He then questioned whether Wallace himself could answer the last five questions on the exam noting their difficulty. I was instantly
Details

We all know one size never fits all, yet, for the vast majority of medical history, care providers have been using that approach. Fortunately, with the advances in molecular and genetic medicine, precision medicine has become a viable alternative to the outdated and inefficient one-size-fits-all approach. Precision medicine, as the name suggests, does not concern
Details

Many debates have been held on the merits of social media. When it comes to the health care industry, the terms “key opinion leaders (KOLs)” and “Twitter” tend not to belong in the same sentence. Understandably as historically, health care practitioners in general have tended to be laggers not leaders, when it comes to technology
Details

Often the sites of harrowing injuries, trauma centers are a vital part of the U.S healthcare system. Trauma centers save lives. According to the New England Journal of Medicine, victims treated at trauma centers have a 25% higher survival rate when compared with treatment at non-trauma hospitals. The simple assertion that trauma centers save lives
Details

In the last decade, the transition from volume- to value-based health care delivery ushers in a trend of preventive care. As a result of the Affordable Health Care Act, Medicare covers a preventative health benefit. This is known as an Annual Wellness Visit (AWV). From 2011 to 2015, the percentage of Medicare Advantage enrollees who
Details

Grimacing in pain, a man stumbles into a packed emergency room. Empty seats are nonexistent. Through heavy breaths, the man croaks a cough. Scowls from across the room pierce the man. After running some tests, the doctors conclude that the man has acute bronchitis. News of harrowing scenes in hospitals treating COVID-19 has distracted from
Details